Persistent immune activation in HIV-1 infection is associated with progression to AIDS

HIV-1 infection is characterized by chronic generalized CD8 and CD4 T cell hyperactivation, the biological effect of which is not understood. To study the relation between chronic immune activation and CD4 T cell depletion in HIV-1 infection. Prospective cohort study among participants of the Amster...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 2003-09, Vol.17 (13), p.1881-1888
Hauptverfasser: HAZENBERG, Mette D, OTTO, Sigrid A, VAN BENTHEM, Birgit H. B, ROOS, Marijke Th. L, COUTINHO, Roel A, LANGE, Joep M. A, HAMANN, Dörte, PRINS, Maria, MIEDEMA, Frank
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1888
container_issue 13
container_start_page 1881
container_title AIDS (London)
container_volume 17
creator HAZENBERG, Mette D
OTTO, Sigrid A
VAN BENTHEM, Birgit H. B
ROOS, Marijke Th. L
COUTINHO, Roel A
LANGE, Joep M. A
HAMANN, Dörte
PRINS, Maria
MIEDEMA, Frank
description HIV-1 infection is characterized by chronic generalized CD8 and CD4 T cell hyperactivation, the biological effect of which is not understood. To study the relation between chronic immune activation and CD4 T cell depletion in HIV-1 infection. Prospective cohort study among participants of the Amsterdam Cohort Studies on HIV-1 infection and AIDS who have a known seroconversion date (n = 102). CD4 and CD8 T cell activation marker expression was analysed by FACScan before and after seroconversion (1 and 5 years after seroconversion); T cell proliferation and T cell numbers were also measured. Cox proportional hazard analyses were used to study the predictive value of these parameters for progression to AIDS. Preseroconversion low CD4 T cell numbers or elevated levels of CD4 T cell activation were associated with increased risk for development of AIDS after HIV-1 seroconversion. Progression to AIDS was associated with loss of both CD4 and CD8 naive T cells. The predictive value of CD8 T cell activation was confirmed and, in addition, in the course of infection low CD4 T cell counts and increasing proportions of dividing CD4 T cells, dividing CD8 T cells or elevated CD4 T cell activation marker expression became independent predictors of progression to AIDS. Increased T cell activation has predictive value for HIV-1 disease progression even before seroconversion. These data support the hypothesis that persistent hyperactivation of the immune system may lead to erosion of the naive T cell pool and CD4 T cell depletion.
doi_str_mv 10.1097/00002030-200309050-00006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73650441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73650441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-b8e81344a792b7a9196bd2f6f9e67daea0cff842ff77cf30643401bf3cc5bdd23</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EoqXwC8gb2AXGdmLHy6o8WqkSSEC3kePYYNQkJeOC-HtSWqgX49GdMw9dQiiDKwZaXUP_OAhIOPRRQwbJRpIHZMhSJZIsU-yQDIFLnWihYEBOEN97IoM8PyYDxrWEnMOQLB5dhwGjayINdb1uHDU2hk8TQ9vQ0NDpbJGwPvHObiWkBrG1wURX0a8Q3-iqa187h7gpx5aOZzdPp-TImyW6s90_Ii93t8-TaTJ_uJ9NxvPECs1iUuYuZyJNjdK8VEYzLcuKe-m1k6oyzoD1Pk-590pZL0CmIgVWemFtVlYVFyNyuZ3b3_CxdhiLOqB1y6VpXLvGQgmZQZqyHsy3oO1axM75YtWF2nTfBYNi42nx52nx7-mvJPvW892OdVm7at-4M7EHLnaAQWuWvjONDbjnMtC5VFz8ANxgfuY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73650441</pqid></control><display><type>article</type><title>Persistent immune activation in HIV-1 infection is associated with progression to AIDS</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>HAZENBERG, Mette D ; OTTO, Sigrid A ; VAN BENTHEM, Birgit H. B ; ROOS, Marijke Th. L ; COUTINHO, Roel A ; LANGE, Joep M. A ; HAMANN, Dörte ; PRINS, Maria ; MIEDEMA, Frank</creator><creatorcontrib>HAZENBERG, Mette D ; OTTO, Sigrid A ; VAN BENTHEM, Birgit H. B ; ROOS, Marijke Th. L ; COUTINHO, Roel A ; LANGE, Joep M. A ; HAMANN, Dörte ; PRINS, Maria ; MIEDEMA, Frank</creatorcontrib><description>HIV-1 infection is characterized by chronic generalized CD8 and CD4 T cell hyperactivation, the biological effect of which is not understood. To study the relation between chronic immune activation and CD4 T cell depletion in HIV-1 infection. Prospective cohort study among participants of the Amsterdam Cohort Studies on HIV-1 infection and AIDS who have a known seroconversion date (n = 102). CD4 and CD8 T cell activation marker expression was analysed by FACScan before and after seroconversion (1 and 5 years after seroconversion); T cell proliferation and T cell numbers were also measured. Cox proportional hazard analyses were used to study the predictive value of these parameters for progression to AIDS. Preseroconversion low CD4 T cell numbers or elevated levels of CD4 T cell activation were associated with increased risk for development of AIDS after HIV-1 seroconversion. Progression to AIDS was associated with loss of both CD4 and CD8 naive T cells. The predictive value of CD8 T cell activation was confirmed and, in addition, in the course of infection low CD4 T cell counts and increasing proportions of dividing CD4 T cells, dividing CD8 T cells or elevated CD4 T cell activation marker expression became independent predictors of progression to AIDS. Increased T cell activation has predictive value for HIV-1 disease progression even before seroconversion. These data support the hypothesis that persistent hyperactivation of the immune system may lead to erosion of the naive T cell pool and CD4 T cell depletion.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/00002030-200309050-00006</identifier><identifier>PMID: 12960820</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Acquired Immunodeficiency Syndrome - immunology ; AIDS/HIV ; Biological and medical sciences ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Cell Division - immunology ; Disease Progression ; Follow-Up Studies ; HIV Infections - immunology ; HIV Seropositivity - immunology ; HIV-1 ; Human viral diseases ; Humans ; Infectious diseases ; Ki-67 Antigen - blood ; Lymphocyte Activation ; Medical sciences ; Prognosis ; Prospective Studies ; RNA, Viral - blood ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>AIDS (London), 2003-09, Vol.17 (13), p.1881-1888</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-b8e81344a792b7a9196bd2f6f9e67daea0cff842ff77cf30643401bf3cc5bdd23</citedby><cites>FETCH-LOGICAL-c391t-b8e81344a792b7a9196bd2f6f9e67daea0cff842ff77cf30643401bf3cc5bdd23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15098672$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12960820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAZENBERG, Mette D</creatorcontrib><creatorcontrib>OTTO, Sigrid A</creatorcontrib><creatorcontrib>VAN BENTHEM, Birgit H. B</creatorcontrib><creatorcontrib>ROOS, Marijke Th. L</creatorcontrib><creatorcontrib>COUTINHO, Roel A</creatorcontrib><creatorcontrib>LANGE, Joep M. A</creatorcontrib><creatorcontrib>HAMANN, Dörte</creatorcontrib><creatorcontrib>PRINS, Maria</creatorcontrib><creatorcontrib>MIEDEMA, Frank</creatorcontrib><title>Persistent immune activation in HIV-1 infection is associated with progression to AIDS</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>HIV-1 infection is characterized by chronic generalized CD8 and CD4 T cell hyperactivation, the biological effect of which is not understood. To study the relation between chronic immune activation and CD4 T cell depletion in HIV-1 infection. Prospective cohort study among participants of the Amsterdam Cohort Studies on HIV-1 infection and AIDS who have a known seroconversion date (n = 102). CD4 and CD8 T cell activation marker expression was analysed by FACScan before and after seroconversion (1 and 5 years after seroconversion); T cell proliferation and T cell numbers were also measured. Cox proportional hazard analyses were used to study the predictive value of these parameters for progression to AIDS. Preseroconversion low CD4 T cell numbers or elevated levels of CD4 T cell activation were associated with increased risk for development of AIDS after HIV-1 seroconversion. Progression to AIDS was associated with loss of both CD4 and CD8 naive T cells. The predictive value of CD8 T cell activation was confirmed and, in addition, in the course of infection low CD4 T cell counts and increasing proportions of dividing CD4 T cells, dividing CD8 T cells or elevated CD4 T cell activation marker expression became independent predictors of progression to AIDS. Increased T cell activation has predictive value for HIV-1 disease progression even before seroconversion. These data support the hypothesis that persistent hyperactivation of the immune system may lead to erosion of the naive T cell pool and CD4 T cell depletion.</description><subject>Acquired Immunodeficiency Syndrome - immunology</subject><subject>AIDS/HIV</subject><subject>Biological and medical sciences</subject><subject>CD4 Lymphocyte Count</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cell Division - immunology</subject><subject>Disease Progression</subject><subject>Follow-Up Studies</subject><subject>HIV Infections - immunology</subject><subject>HIV Seropositivity - immunology</subject><subject>HIV-1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Ki-67 Antigen - blood</subject><subject>Lymphocyte Activation</subject><subject>Medical sciences</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>RNA, Viral - blood</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtOwzAQRS0EoqXwC8gb2AXGdmLHy6o8WqkSSEC3kePYYNQkJeOC-HtSWqgX49GdMw9dQiiDKwZaXUP_OAhIOPRRQwbJRpIHZMhSJZIsU-yQDIFLnWihYEBOEN97IoM8PyYDxrWEnMOQLB5dhwGjayINdb1uHDU2hk8TQ9vQ0NDpbJGwPvHObiWkBrG1wURX0a8Q3-iqa187h7gpx5aOZzdPp-TImyW6s90_Ii93t8-TaTJ_uJ9NxvPECs1iUuYuZyJNjdK8VEYzLcuKe-m1k6oyzoD1Pk-590pZL0CmIgVWemFtVlYVFyNyuZ3b3_CxdhiLOqB1y6VpXLvGQgmZQZqyHsy3oO1axM75YtWF2nTfBYNi42nx52nx7-mvJPvW892OdVm7at-4M7EHLnaAQWuWvjONDbjnMtC5VFz8ANxgfuY</recordid><startdate>20030905</startdate><enddate>20030905</enddate><creator>HAZENBERG, Mette D</creator><creator>OTTO, Sigrid A</creator><creator>VAN BENTHEM, Birgit H. B</creator><creator>ROOS, Marijke Th. L</creator><creator>COUTINHO, Roel A</creator><creator>LANGE, Joep M. A</creator><creator>HAMANN, Dörte</creator><creator>PRINS, Maria</creator><creator>MIEDEMA, Frank</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030905</creationdate><title>Persistent immune activation in HIV-1 infection is associated with progression to AIDS</title><author>HAZENBERG, Mette D ; OTTO, Sigrid A ; VAN BENTHEM, Birgit H. B ; ROOS, Marijke Th. L ; COUTINHO, Roel A ; LANGE, Joep M. A ; HAMANN, Dörte ; PRINS, Maria ; MIEDEMA, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-b8e81344a792b7a9196bd2f6f9e67daea0cff842ff77cf30643401bf3cc5bdd23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acquired Immunodeficiency Syndrome - immunology</topic><topic>AIDS/HIV</topic><topic>Biological and medical sciences</topic><topic>CD4 Lymphocyte Count</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cell Division - immunology</topic><topic>Disease Progression</topic><topic>Follow-Up Studies</topic><topic>HIV Infections - immunology</topic><topic>HIV Seropositivity - immunology</topic><topic>HIV-1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Ki-67 Antigen - blood</topic><topic>Lymphocyte Activation</topic><topic>Medical sciences</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>RNA, Viral - blood</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAZENBERG, Mette D</creatorcontrib><creatorcontrib>OTTO, Sigrid A</creatorcontrib><creatorcontrib>VAN BENTHEM, Birgit H. B</creatorcontrib><creatorcontrib>ROOS, Marijke Th. L</creatorcontrib><creatorcontrib>COUTINHO, Roel A</creatorcontrib><creatorcontrib>LANGE, Joep M. A</creatorcontrib><creatorcontrib>HAMANN, Dörte</creatorcontrib><creatorcontrib>PRINS, Maria</creatorcontrib><creatorcontrib>MIEDEMA, Frank</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAZENBERG, Mette D</au><au>OTTO, Sigrid A</au><au>VAN BENTHEM, Birgit H. B</au><au>ROOS, Marijke Th. L</au><au>COUTINHO, Roel A</au><au>LANGE, Joep M. A</au><au>HAMANN, Dörte</au><au>PRINS, Maria</au><au>MIEDEMA, Frank</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Persistent immune activation in HIV-1 infection is associated with progression to AIDS</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2003-09-05</date><risdate>2003</risdate><volume>17</volume><issue>13</issue><spage>1881</spage><epage>1888</epage><pages>1881-1888</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>HIV-1 infection is characterized by chronic generalized CD8 and CD4 T cell hyperactivation, the biological effect of which is not understood. To study the relation between chronic immune activation and CD4 T cell depletion in HIV-1 infection. Prospective cohort study among participants of the Amsterdam Cohort Studies on HIV-1 infection and AIDS who have a known seroconversion date (n = 102). CD4 and CD8 T cell activation marker expression was analysed by FACScan before and after seroconversion (1 and 5 years after seroconversion); T cell proliferation and T cell numbers were also measured. Cox proportional hazard analyses were used to study the predictive value of these parameters for progression to AIDS. Preseroconversion low CD4 T cell numbers or elevated levels of CD4 T cell activation were associated with increased risk for development of AIDS after HIV-1 seroconversion. Progression to AIDS was associated with loss of both CD4 and CD8 naive T cells. The predictive value of CD8 T cell activation was confirmed and, in addition, in the course of infection low CD4 T cell counts and increasing proportions of dividing CD4 T cells, dividing CD8 T cells or elevated CD4 T cell activation marker expression became independent predictors of progression to AIDS. Increased T cell activation has predictive value for HIV-1 disease progression even before seroconversion. These data support the hypothesis that persistent hyperactivation of the immune system may lead to erosion of the naive T cell pool and CD4 T cell depletion.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>12960820</pmid><doi>10.1097/00002030-200309050-00006</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-9370
ispartof AIDS (London), 2003-09, Vol.17 (13), p.1881-1888
issn 0269-9370
1473-5571
language eng
recordid cdi_proquest_miscellaneous_73650441
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Acquired Immunodeficiency Syndrome - immunology
AIDS/HIV
Biological and medical sciences
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Cell Division - immunology
Disease Progression
Follow-Up Studies
HIV Infections - immunology
HIV Seropositivity - immunology
HIV-1
Human viral diseases
Humans
Infectious diseases
Ki-67 Antigen - blood
Lymphocyte Activation
Medical sciences
Prognosis
Prospective Studies
RNA, Viral - blood
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
title Persistent immune activation in HIV-1 infection is associated with progression to AIDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T22%3A06%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Persistent%20immune%20activation%20in%20HIV-1%20infection%20is%20associated%20with%20progression%20to%20AIDS&rft.jtitle=AIDS%20(London)&rft.au=HAZENBERG,%20Mette%20D&rft.date=2003-09-05&rft.volume=17&rft.issue=13&rft.spage=1881&rft.epage=1888&rft.pages=1881-1888&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/00002030-200309050-00006&rft_dat=%3Cproquest_cross%3E73650441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73650441&rft_id=info:pmid/12960820&rfr_iscdi=true